Muncie, IN – According to filings with the U.S. Securities and Exchange Commission, Early is Good is raising $4,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Thakshila Liyanage played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Early is Good
Our mission is to enable the early, accurate, and widely accessible detection of renal system diseases, including bladder, kidney, and prostate cancers, by assessing specific biomarkers found in urine. EIG believes that earlier detection yields better outcomes and focuses on developing highly sensitive, accurate, and non-invasive diagnostic tests for early diagnosis and management care of cancer.

To learn more about Early is Good, visit http://earlyisgood.com/

Contact:
Thakshila Liyanage, Chief Executive Officer
317-650-5078
https://www.linkedin.com/in/thakshila-liyanage-75392b22/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved